Cargando…

E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING

Ring-finger protein 5 (RNF5) is an E3 ubiquitin ligase which is expressed in a variety of human tissues. RNF5 is involved in the regulation of endoplasmic reticulum stress, inflammation, and innate immunity and plays an important role in the occurrence and development of various tumors. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lu-Lu, Xiao, Wen-Chang, Li, Huan, Hao, Zheng-Yang, Liu, Gui-Zhi, Zhang, Dian-Hong, Wu, Lei-Ming, Wang, Zheng, Zhang, Yan-Qing, Huang, Zhen, Zhang, Yan-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587004/
https://www.ncbi.nlm.nih.gov/pubmed/36270989
http://dx.doi.org/10.1038/s41419-022-05231-8
_version_ 1784813812513243136
author Yang, Lu-Lu
Xiao, Wen-Chang
Li, Huan
Hao, Zheng-Yang
Liu, Gui-Zhi
Zhang, Dian-Hong
Wu, Lei-Ming
Wang, Zheng
Zhang, Yan-Qing
Huang, Zhen
Zhang, Yan-Zhou
author_facet Yang, Lu-Lu
Xiao, Wen-Chang
Li, Huan
Hao, Zheng-Yang
Liu, Gui-Zhi
Zhang, Dian-Hong
Wu, Lei-Ming
Wang, Zheng
Zhang, Yan-Qing
Huang, Zhen
Zhang, Yan-Zhou
author_sort Yang, Lu-Lu
collection PubMed
description Ring-finger protein 5 (RNF5) is an E3 ubiquitin ligase which is expressed in a variety of human tissues. RNF5 is involved in the regulation of endoplasmic reticulum stress, inflammation, and innate immunity and plays an important role in the occurrence and development of various tumors. However, the role of RNF5 in cardiac hypertrophy has not been reported. In this study, we found the expression of RNF5 was increased in the hearts of mice with pathological cardiac hypertrophy. The loss-of-function research demonstrated that RNF5 deficiency exacerbated cardiac hypertrophy, whereas gain-of-function studies revealed that overexpression of RNF5 had opposite effects. The stimulator of interferon genes (STING) is a signaling molecule that can activate type I interferon immunity, which can meditate inflammation and immune response in many diseases. The protein–protein interaction experiments confirmed that STING interacted with RNF5. Further studies showed that RNF5 inhibited cardiac hypertrophy by promoting STING degradation through K48-linked polyubiquitination. Therefore, we defined RNF5 as importantly regulated signaling for cardiac hypertrophy.
format Online
Article
Text
id pubmed-9587004
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95870042022-10-23 E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING Yang, Lu-Lu Xiao, Wen-Chang Li, Huan Hao, Zheng-Yang Liu, Gui-Zhi Zhang, Dian-Hong Wu, Lei-Ming Wang, Zheng Zhang, Yan-Qing Huang, Zhen Zhang, Yan-Zhou Cell Death Dis Article Ring-finger protein 5 (RNF5) is an E3 ubiquitin ligase which is expressed in a variety of human tissues. RNF5 is involved in the regulation of endoplasmic reticulum stress, inflammation, and innate immunity and plays an important role in the occurrence and development of various tumors. However, the role of RNF5 in cardiac hypertrophy has not been reported. In this study, we found the expression of RNF5 was increased in the hearts of mice with pathological cardiac hypertrophy. The loss-of-function research demonstrated that RNF5 deficiency exacerbated cardiac hypertrophy, whereas gain-of-function studies revealed that overexpression of RNF5 had opposite effects. The stimulator of interferon genes (STING) is a signaling molecule that can activate type I interferon immunity, which can meditate inflammation and immune response in many diseases. The protein–protein interaction experiments confirmed that STING interacted with RNF5. Further studies showed that RNF5 inhibited cardiac hypertrophy by promoting STING degradation through K48-linked polyubiquitination. Therefore, we defined RNF5 as importantly regulated signaling for cardiac hypertrophy. Nature Publishing Group UK 2022-10-21 /pmc/articles/PMC9587004/ /pubmed/36270989 http://dx.doi.org/10.1038/s41419-022-05231-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yang, Lu-Lu
Xiao, Wen-Chang
Li, Huan
Hao, Zheng-Yang
Liu, Gui-Zhi
Zhang, Dian-Hong
Wu, Lei-Ming
Wang, Zheng
Zhang, Yan-Qing
Huang, Zhen
Zhang, Yan-Zhou
E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
title E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
title_full E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
title_fullStr E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
title_full_unstemmed E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
title_short E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING
title_sort e3 ubiquitin ligase rnf5 attenuates pathological cardiac hypertrophy through sting
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587004/
https://www.ncbi.nlm.nih.gov/pubmed/36270989
http://dx.doi.org/10.1038/s41419-022-05231-8
work_keys_str_mv AT yanglulu e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT xiaowenchang e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT lihuan e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT haozhengyang e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT liuguizhi e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT zhangdianhong e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT wuleiming e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT wangzheng e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT zhangyanqing e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT huangzhen e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting
AT zhangyanzhou e3ubiquitinligasernf5attenuatespathologicalcardiachypertrophythroughsting